Concepedia

Author

Carl G. Kardinal

Mayo Clinic

Also Known As

C G Kardinal, C Kardinal, C. G. Kardinal, C. Kardinal, C.G Kardinal, Carl G Kardinal, Carl G. Kardinal, Carl Kardinal

92

Publications

5.5K

Citations

32

H-Index

51

Concepts

All Affiliations

Mayo ClinicOchsner Medical CenterDuluth ClinicIowa Oncology Research AssociationMissouri Valley Cancer Consortium
CG

About

Carl G. Kardinal is an author at Mayo Clinic specializing in medicine, oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

24

3.5K

2

Health Sciences

3

3

413

3

Nursing

1

1

11

4

Public Health

1

1

68

5

Clinical Nutrition

1

1

353

Carl G. Kardinal

×

47

Publications

5.4K

Citations

32

H-Index

YearCitations

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial

Bernard Fisher, James J. Dignam, Norman Wolmark,

The Lancet

1999

1K

Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.

Bernard Fisher, Ann Brown, N V Dimitrov,

Journal of Clinical Oncology

1990

627

Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal cancer.

Michael A. Poon, M. J. OʼConnell, Harry S. Wieand,

Journal of Clinical Oncology

1991

374

Dronabinol Versus Megestrol Acetate Versus Combination Therapy for Cancer-Associated Anorexia: A North Central Cancer Treatment Group Study

Aminah Jatoi, Harold E. Windschitl, Charles L. Loprinzi,

Journal of Clinical Oncology

2002

353

Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal cancer.

T Buroker, M J O'Connell, Harry S. Wieand,

Journal of Clinical Oncology

1994

312

Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23

Bernard Fisher, Stewart Anderson, Elizabeth Tan-Chiu,

Journal of Clinical Oncology

2001

275

Further Evaluation of Intensified and Increased Total Dose of Cyclophosphamide for the Treatment of Primary Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-25

Bernard Fisher, Stewart Anderson, Arthur P. DeCillis,

Journal of Clinical Oncology

1999

228

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

Carl G. Kardinal, Charles L. Loprinzi, Daniel J. Schaid,

Cancer

1990

226

A phase III trial on the therapy of advanced pancreatic carcinoma evaluations of the mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin

Stephen A. Cullinan, Charles G. Moertel, Harry S. Wieand,

Cancer

1990

207

Two Concurrent Phase II Trials of Paclitaxel/Carboplatin/Trastuzumab (Weekly or Every-3-Week Schedule) as First-Line Therapy in Women with HER2-Overexpressing Metastatic Breast Cancer: NCCTG Study 983252

Edith A. Perez, Vera J. Suman, Kendrith M. Rowland,

Clinical Breast Cancer

2005

137

Page 1